PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene

Autor: Guo, Zhuyan, Wang, Anlai, Zhang, Weidong, Levit, Mikhail, Gao, Qiang, Barberis, Claude, Tabart, Michel, Zhang, Jingxin, Hoffmann, Dietmar, Wiederschain, Dmitri, Rocnik, Jennifer, Sun, Fangxian, Murtie, Josh, Lengauer, Christoph, Gross, Stefan, Zhang, Bailin, Cheng, Hong, Patel, Vinod, Schio, Laurent, Adrian, Francisco, Dorsch, Marion, Garcia-Echeverria, Carlos, Huang, Shih-Min A. *
Zdroj: In Blood 11 September 2014 124(11):1777-1789
Databáze: ScienceDirect